Dopamine receptor (D4) polymorphism is related to comorbidity between marijuana abuse and depression

Addictive Behaviors

Volumn 38, Issue 10, 2013, Pages 2555-2562

  Bobadilla, Leonardo ^a   Vaske, Jamie ^a   Asberg, Kia ^a  

^a WESTERN CAROLINA UNIVERSITY   (United States)

Author keywords

Comorbidity; Depressive symptoms; DRD4; Marijuana use

Indexed keywords

DOPAMINE 4 RECEPTOR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CANNABIS ADDICTION; COMORBIDITY; DEPRESSION; DNA POLYMORPHISM; ETHNIC DIFFERENCE; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; VARIABLE NUMBER OF TANDEM REPEAT; VIOLENCE;

COMORBIDITY; DEPRESSIVE SYMPTOMS; DRD4; MARIJUANA USE;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADULT; ALLELES; COMORBIDITY; DEPRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIMBIC SYSTEM; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MARIJUANA ABUSE; MINISATELLITE REPEATS; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; PSYCHOPATHOLOGY; RECEPTORS, DOPAMINE D4; REWARD; SIBLINGS; UNITED STATES; YOUNG ADULT;

EID: 84879538112     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2013.05.014     Document Type: Article

References (56)

1. Add Health Biomarker Team Biomarkers in wave III of the Add Health Study 2003, Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
2. Adkins D.E., Daw J.K., McClay J.L., van den Oord E.J.C.G. The influence of five monoamine genes on trajectories of depressive symptoms across adolescence and young adulthood. Development and Psychopathology 2012, 24:267-285.
3. Alcaro A., Panksepp J. The SEEKING mind: Primal neuro-affective substrates for appetitive incentive states and their pathological dynamics in addictions and depression. Neuroscience and Biobehavioral Reviews 2011, 35(9):1805-1820.
4. Amato L., Minozzi S., Pani P., Solimini R., Vecchi S., Zuccaro P., et al. Dopamine agonists for the treatment of cocaine dependence. Cochrane Database of Systematic Reviews (Online) 2011, 12:CD003352.
5. Asghari V., Sanyal S., Buchwaldt S., Paterson A., Jovanovic V., Van Tol H.H.M. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. Journal of Neurochemistry 1995, 65(3):1157-1165.
6. Blum K., Cull J.G., Braverman E.R., Chen T.H., Comings D.E. Reward deficiency syndrome: Neurobiological and genetic aspects. Handbook of psychiatric genetics 1997, 311-327. CRC Press, Boca Raton, FL US. K. Blum, E.P. Noble, R.S. Sparkes, T.J. Chen (Eds.).
7. Buckner J.D., Schmidt N.B., Lang A.R., Small J.W., Schlauch R.C., Lewinsohn P.M. Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependence. Journal of Psychiatric Research 2008, 42(3):230-239. 10.1016/j.jpsychires.2007.01.002.
8. Cerdá M.M., Sagdeo A.A., Johnson J.J., Galea S.S. Genetic and environmental influences on psychiatric comorbidity: A systematic review. Journal of Affective Disorders 2010, 126(1-2):14-38. 10.1016/j.jad.2009.11.006.
9. Cooper M.I., Frone M.R., Rusell M., Mudar P. Drinking to regulate positive and negative moods: A motivational model alcohol use. Journal of Personality and Social Psychology 1995, 69:990-1005.
10. Creemers H., Harakeh Z., Dick D., Meyers J., Vollebergh W., Ormel J., et al. DRD2 and DRD4 in relation to regular alcohol and cannabis use among adolescents: Does parenting modify the impact of genetic vulnerability? The TRAILS study. Drug and Alcohol Dependence 2011, 115(1-2):35-42.
11. Faul F., Erdfelder E., Lang A.-G., Buchner A. G*Power 3: A flexible statistical power analysis for the social, behavioral, and biomedical sciences. Behavior Research Methods 2007, 39:175-191.
12. Fergusson D.M., Boden J.M., Horwood L. Structural models of the comorbidity of internalizing disorders and substance use disorders in a longitudinal birth cohort. Social Psychiatry and Psychiatric Epidemiology 2011, 46(10):933-942. 10.1007/s00127-010-0268-1.
13. Filbey F.M., Schacht J.P., Myers U.S., Chavez R.S., Hutchison K.E. Marijuana craving in the brain. PNAS Proceedings of the National Academy of Sciences of the United States of America 2009, 106(31):13016-13021. 10.1073/pnas.0903863106.
14. Fu Q., Heath A.C., Bucholz K.K., Nelson E., Goldberg J., Lyons M.J., et al. Shared genetic risk of major depression, alcohol dependence, and marijuana dependence: Contribution of antisocial personality disorder in men. Archives of General Psychiatry 2002, 59(12):1125-1132. 10.1001/archpsyc.59.12.1125.
15. Gauderman W.J., Morrison J.M. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiological studies http://hydra.usc.edu/gxe.
16. Gelernter J., Kranzler H., Coccaro E., Siever L., New A., Mulgrew C. D4 dopamine-receptor (DRD4) alleles and novelty seeking in substance-dependent, personality-disorder, and control subjects. American Journal of Human Genetics 1997, 61(5):1144-1152.
17. Guo G., Roettger M., Shih J. Contributions of the DAT1 and DRD2 genes to serious and violent delinquency among adolescents and young adults. Human Genetics 2007, 121(1):125-136.
18. Guo G., Tillman K.H. Trajectories of depressive symptoms, dopamine D2 and D4 receptors, family socioeconomic status and social support in adolescence and young adulthood. Psychiatric Genetics 2009, 19:14-26.
19. Hendershot C.S., Neighbors C., George W.H., McCarthy D.M., Wall T.L., Liang T., et al. ALDH2, ADH1B and alcohol expectancies: Integrating genetic and learning perspectives. Psychology of Addictive Behaviors 2009, 23(3):452-463. 10.1037/a0016629.
20. Huang S., Lin W., Ko H., Lee J., Wang T., Chou Y., et al. Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence. Alcoholism, Clinical and Experimental Research 2004, 28(3):374-384. 10.1097/01.ALC.0000117832.62901.61.
21. Hutchinson K.E., McGeary J., Smolen A., Bryan A., Swift R.M. The DRD4 VNTR polymorphism moderates craving after alcohol consumption. Health Psychology 2002, 21(2):139-146. 10.1037/0278-6133.21.2.139.
22. James L., Taylor J. Revisiting the structure of mental disorders: Borderline personality disorder and the internalizing/externalizing spectra. British Journal of Clinical Psychology 2008, 47(Part 4):361-380.
23. Johnston L.D., O'Malley P.M., Bachman J.G., Schulenberg J.E. Marijuana use is rising; ecstasy use is beginning to rise; and alcohol use is declining among U.S. teens 2010, December 14, University of Michigan News Service, Ann Arbor, MI, (Retrieved 03/03/2012 from http://www.monitoringthefuture.org).
24. Kessler R.C., Ormel J., Petukhova M., McLaughlin K.A., Green J., Russo L.J., et al. Development of lifetime comorbidity in the World Health Organization World Mental Health Surveys. Archives of General Psychiatry 2011, 68(1):90-100. 10.1001/archgenpsychiatry.2010.180.
25. Kilpatrick D.G., Acierno R., Saunders B., Resnick H.S., Best C.L., Schnurr P.P. Risk factors for adolescent substance abuse and dependence: Data from a national sample. Journal of Consulting and Clinical Psychology 2000, 68(1):19-30.
26. Krueger R.F. The structure of common mental disorders. Archives of General Psychiatry 1999, 56(10):921-926. 10.1001/archpsyc.56.10.921.
27. Krueger R.F., Caspi A., Moffitt T.E., Silva P.A. The structure and stability of common mental disorders (DSM-III-R): A longitudinal-epidemiological study. Journal of Abnormal Psychology 1998, 107(2):216-227. 10.1037/0021-843X.107.2.216.
28. Leentjens A. The role of dopamine agonists in the treatment of depression in patients with Parkinson's disease: A systematic review. Drugs 2011, 71(3):273-286. 10.2165/11585380-000000000-00000.
29. Lin S., Wu P., Ko H., Wu J., Huang S., Lin W., et al. Specific personality traits and dopamine, serotonin genes in anxiety-depressive alcoholism among Han Chinese in Taiwan. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2007, 31(7):1526-1534. 10.1016/j.pnpbp.2007.07.012.
30. López León S., Croes E.A., Sayed-Tabatabaei F.A., Claes S., Broeckhoven C.V., van Duijn C.M. The dopamine D4 receptor gene 48-base-pair-repeat polymorphism and mood disorders: A meta-analysis. Biological Psychiatry 2005, 57(9):999-1003.
31. Malone D., Hill M., Rubino T. Adolescent cannabis use and psychosis: Epidemiology and neurodevelopmental models. British Journal of Pharmacology 2010, 160(3):511-522.
32. Marmorstein N.R., White H., Tammy C., Hipwell A., Stouthamer-Loeber M., Loeber R. Associations between first use of substances and change in internalizing symptoms among girls: Differences by symptom trajectory and substance use type. Journal of Clinical Child and Adolescent Psychology 2010, 39(4):545-558. 10.1080/15374416.2010.486325.
33. Marques F.C., Hutz M.H., Bau C.D. Influence of the serotonin transporter gene on comorbid disorders among alcohol-dependent individuals. Psychiatric Genetics 2006, 16(3):125-131. 10.1097/01.ypg.0000199449.07786.7d.
34. McGeary J. The DRD4 exon 3 VNTR polymorphism and addiction-related phenotypes: A review. Pharmacology Biochemistry and Behavior 2009, 93:222-229.
35. McGeary J.E., Esposito-Smythers C., Spirito A., Monti P.M. Associations of the dopamine D4 receptor gene VNTR polymorphism with drug use in adolescent psychiatric inpatients. Pharmacology, Biochemistry, and Behavior 2007, 86(2):401-406. 10.1016/j.pbb.2006.11.001.
36. Merikangas K.R., Mehta R.L., Molnar B.E., Walters E.E., Swendsen J.D., Auilar-Gaziola S., et al. Comorbidity of substance use disorders with mood and anxiety disorders: Results of the International Consortium in Psychiatric Epidemiology. Addictive Behaviors 1998, 23(6):893-908. 10.1016/S0306-4603(98)00076-8.
37. Nederhof E., Bouma E., Riese H., Laceulle O., Ormel J., Oldehinkel A. Evidence for plasticity genotypes in a gene-gene-environment interaction: The TRAILS study. Genes, Brain, and Behavior 2010, 9(8):968-973. 10.1111/j.1601-183X.2010.00637.x.
38. Nestler E.J., Carlezon W.A. The mesolimbic dopamine reward circuit in depression. Biological Psychiatry 2006, 59(12):1151-1159. 10.1016/j.biopsych.2005.09.018.
39. Neville M., Johnstone E., Walton R. Identification and characterization of ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Human Mutation 2004, 23(6):540-545.
40. Noble E. Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: A review. European Psychiatry: The Journal of the Association of European Psychiatrists 2000, 15(2):79-89.
41. O'Connor T.G., McGuire S., Reiss D., Hetherington E., Plomin R. Co-occurrence of depressive symptoms and antisocial behavior in adolescence: A common genetic liability. Journal of Abnormal Psychology 1998, 107(1):27-37. 10.1037/0021-843X.107.1.27.
42. Olsson C.A., Moyzis R.K., Williamson E., Ellis J.E., Parkinson-Bates M., Patton G.C., et al. Gene-environment interaction in problematic substance use: Interaction between DRD4 and insecure attachments. Addiction Biology 2011, (Early View Online Version). 10.1111/j.1369-1600.2011.00413.x.
43. Primus R.J., Thurkauf A., Xu J., Yevich E., Mcinerney S., Shaw K., et al. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H] NGD 94-1. Journal of Pharmacology and Experimental Therapeutics 1997, 282(2):1020-1027.
44. Radloff L.S. The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement 1977, 1:385-401.
45. Rodriguez S., Gaunt T.R., Day I.N.M. Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. American Journal of Epidemiology 2009, 169:505-514.
46. Schoots O., Van Tol H.H.M. The human dopamine D4 receptor repeat sequences modulate expression. The Pharmacogenomics Journal 2003, 3:343-348.
47. Silver E., Arseneault L., Langley J., Caspi A., Moffitt T.E. Mental disorder and violent victimization in a total birth cohort. American Journal of Public Health 2005, 95(11):2015-2021.
48. Steuber T.L., Banner F. Adolescent smoking and depression: Which comes first?. Addictive Behaviors 2006, 31(1):133-136. 10.1016/j.addbeh.2005.04.010.
49. Van Craenenbroeck K., Clark S.D., Cox M.J., Oak J.N., Liu F., Van Tol H.H.M. Folding efficiency is rate-limiting in dopamine D4 receptor biogenesis. Journal of Biological Chemistry 2005, 280(19):19350-19357.
50. Van Der Zwaluw C.S., Larsen H., Engels R.E. Best friends and alcohol use in adolescence: The role of the dopamine D4 receptor gene. Addiction Biology 2012, 17(6):1036-1045. 10.1111/j.1369-1600.2010.00305.x.
51. Van Laar M., Van Dorsselaer S., Monshouwer K., De Graaf R. Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population?. Addiction 2007, 102(8):1251-1260.
52. Vandenbergh D.J., Rodriguez L.A., Hivert E., Schiller J.H., Villareal G., Pugh E.W., et al. Long forms of the dopamine receptor (DRD4) gene VNTR are more prevalent in substance abusers: No interaction with functional alleles of the catechol-o-methyltransferase (COMT) gene. American Journal of Medical Genetics 2000, 96(5):678-683.
53. Vaske J. Genes and abuse as causes of offending 2011, LFB Scholarly, El Paso, TX.
54. White A.M., Jordan J.D., Schroeder K.M., Acheson S.K., Georgi B.D., Sauls G., et al. Predictors of relapse during treatment and treatment completion among marijuana-dependent adolescents in an intensive outpatient substance abuse program. Substance Abuse 2004, 25(1):53-59. 10.1300/J465v25n01_08.
55. Xiang L., Szebeni K., Szebeni A., Klimek V., Stockmeier C., Karolewicz B., et al. Dopamine receptor gene expression in human amygdaloid nuclei: Elevated D4 receptor mRNA in major depression. Brain Research 2008, 120:7214-7224. 10.1016/j.brainres.2008.02.009.
56. Zuckerman M., Kuhlman D. Personality and risk-taking: Common biosocial factors. Journal of Personality 2000, 68(6):999-1029. 10.1111/1467-6494.00124.